Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 1 26Phase 3 12Phase 1/2 12Phase NA 3Phase 2/3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Other 1

Conditions

Breast Neoplasms 11Pancreatic Neoplasms 7Rectal Neoplasms 6Neoplasms 3Colorectal Neoplasms 3Stomach Neoplasms 2Solid Tumors 1Obesity 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Locally Advanced Rectal Cancer 1Klatskin Tumor 1Hypopharyngeal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Cholangitis, Sclerosing 1Carcinoma, Hepatocellular 1Capecitabine 1Biliary Tract Neoplasms 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Exercise 83Standard of Care 45Blood Specimen Collection 43Methods 32Therapeutics 28Surveys and Questionnaires 27Educational Status 25Control Groups 20Cognitive Behavioral Therapy 20Interviews as Topic 18Music Therapy 15Biopsy 15Acupuncture Therapy 15Palliative Care 14Resistance Training 13Magnetic Resonance Spectroscopy 13Early Intervention, Educational 13Radiotherapy 10Radiosurgery 10Nutrition Assessment 9Behavior Therapy 9Yoga 8Psychiatric Rehabilitation 8Practice Guidelines as Topic 8Patient Navigation 8Counseling 8Ultraviolet Therapy 7Physical Therapy Modalities 7Nutritional Status 7Mindfulness 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Neoplasms × Capecitabine × Clear all
NCT04194957 2020-01-22

Alpe2U

The Netherlands Cancer Institute

Phase NA Unknown
1,440 enrolled
Tumor-Agnostic

Neoplasms

NCT01828554 2019-11-25

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

University of Wisconsin, Madison

Phase NA Completed
8 enrolled 7 charts
Other

Neoplasms, Obesity

NCT02324452 2018-05-11

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

The Netherlands Cancer Institute

Phase NA Completed
1,103 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡